Litcius/Paper detail

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum

Julia Fricke, Frida Westerbergh, Lisa McDougall, Chiara Favaretto, Emanuel Christ, Guillaume Nicolas, Susanne Geistlich, Francesca Borgna, Melpomeni Fani, Peter Bernhardt, Nicholas P. van der Meulen, Cristina Müller, Roger Schibli, Damian Wild

2024European Journal of Nuclear Medicine and Molecular Imaging40 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDOTAAntagonistSomatostatin receptorIleumSomatostatinNeuroendocrine tumourInternal medicinePharmacologyReceptorChemistryChelationOrganic chemistryNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesPancreatic and Hepatic Oncology Research